Anyone feel they’re in a Catch 22 situation? – about applying for extra shares, available from any shortfall.
I’ve just paid for my entitlement + twice as many extra. (Hence my Sentiment = Buy)
The Catch 22 for me is:
If any ANN – of the fluid samples’ analyses/results
a) IS NOT released before the Closing Date of the New Issue (Monday 19 Feb.) then I’ll probably get the extras I’ve applied for, or
b) IS released ….ditto……..
then I probably won’t, because the SP by then will exceed 13.0c, and thus there’ll be no shortfall to distribute to applicants which have applied for some.
What do others think?
